Ligand validation:2RJ5

UDP: URIDINE-5'-DIPHOSPHATE

UDP is a Ligand Of Interest in 2RJ5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2RJ5_UDP_A_1	55%	25%	0.126	0.894	1.41	1.63	2	6	0	0	100%	0.64
6GX2_UDP_A_402	99%	52%	0.053	0.989	0.86	1.01	-	2	0	0	100%	1
5M7C_UDP_B_602	99%	34%	0.053	0.984	1.11	1.49	-	6	0	0	100%	1
3V0Q_UDP_B_402	96%	38%	0.07	0.979	0.96	1.44	1	6	0	0	100%	1
5M7B_UDP_A_602	95%	41%	0.077	0.98	1	1.27	1	5	0	0	100%	1
2RJ8_UDP_A_1	86%	29%	0.083	0.951	1.28	1.53	3	6	0	0	100%	1
8X3Q_UDP_C_401	100%	3%	0.015	0.998	3.32	2.69	13	13	0	0	100%	1
8X3U_UDP_B_401	100%	3%	0.012	0.999	3.31	2.68	13	13	2	0	100%	1
8VH8_UDP_C_704	100%	62%	0.032	0.995	0.55	0.9	-	1	0	0	100%	1
4GYW_UDP_C_1101	100%	37%	0.037	0.988	1.03	1.45	2	4	0	0	100%	1
2IV7_UDP_A_1372	100%	40%	0.035	0.984	0.85	1.49	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.